Eti Mitrany
Vermögen: 405 959 $ am 31.05.2026
Vermögen: 405 959 $ am 31.05.2026
Ms. Eti Mitrany is an Independent Director at Brainsway Ltd., a Chairman at Derma Gene Ltd. and a Chief Executive Officer at Israeli Investors Forum.
She is on the Board of Directors at Trioxnano Ltd. and Brainsway Ltd. Ms. Mitrany was previously employed as a Chief Financial Officer & Head-Corporate Strategy by CytoReason Ltd., a Senior Vice President-Head of Economic by Teva Pharmaceutical Industries Ltd., and a Global Chief Financial Officer by Copaxone.
She received her undergraduate degree from Tel-Aviv University and an MBA from Tel-Aviv University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BRAINSWAY LTD 0,03 % | 26.05.2026 | 12 500 ( 0,03 % ) | 207 334 $ | 31.05.2026 |
| 26.05.2026 | 12 500 ( 0,06 % ) | 198 625 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BRAINSWAY LTD. | Direktor/Vorstandsmitglied | 05.06.2016 |
Trioxnano Ltd. | Direktor/Vorstandsmitglied | 01.01.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
CytoReason Ltd.
CytoReason Ltd. Information Technology ServicesTechnology Services Operates an artificial intelligence that develop computational model of the human body, accurate enough to start replacing animal and human trials in drug | Finanzdirektor/CFO | 01.12.2022 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01.01.2020 |
Copaxone | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brainsway Ltd.
Brainsway Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and markets deep transcranial magnetic stimluation systems, novel, noninvasive medical devices | Health Technology |
Copaxone | |
Trioxnano Ltd. | Commercial Services |
CytoReason Ltd.
CytoReason Ltd. Information Technology ServicesTechnology Services Operates an artificial intelligence that develop computational model of the human body, accurate enough to start replacing animal and human trials in drug | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen